Rising stars
Oncopeptides
Oncopeptides has a new drug candidate for the treatment of a form of cancer of the blood, multiple myeloma, under development. KI Innovations played a key role in getting the project underway.
Aprea Therapeutics
Aprea Therapeutics AB is working on the development of a new p53-based treatment for cancer. Klas Wiman is one of the company’s founders, and he draws a clear distinction between the roles of researcher and entrepreneur.
Encare
The introduction of ERAS Society surgical guidelines results in reduced time spent in hospital and improved patient outcomes. The methods, which are being promoted by the company EnCare, have improved care provision in some 23 countries. One of the people behind the initiative was once a young surgeon at Karolinska University Hospital, critical of the status quo.
Aerocrine
Aerocrine developed the world’s first nitrogen monoxide test for asthma sufferers. Today, the product is used around the globe to monitor asthma symptoms and adjust medication accordingly.
Döbra
The DöBra (“Die Well” ) cards help people to reflect on and talk about their values and preferences for the end of life—a topic that can often be difficult to raise. This tool was developed through an interdisciplinary research programme at Karolinska Institutet and Umeå University, and has contributed to an ongoing process to develop support for social innovations at Karolinska Institutet.
Cellaviva/Nextcell Pharma
Biobank Cellaviva offers parents-to-be the chance to store stem cells from umbilical cord blood and tissue at birth. Experiences from stem cell management have now led to the development of one of Sweden’s first cell therapy drug treatments.
